Skip to content

To assess if application of a topical medicine can resolve the skin damage caused by misuse of steroid creams.

Efficacy of Topical 10% Tranexamic Acid in Topical Steroid Damaged Faces: a non-randomized interventional study. - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056989
Enrollment
12
Registered
2023-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F553- Abuse of steroids or hormones

Interventions

Intervention1: 10% topical tranexamic acid solution: Patient will be advised to apply a solution containing 10% tranexamic acid once daily at night on the affected areas of face for 4weeks. Control In

Sponsors

North Eastern Indira Gandhi Regional Institute of Health and Medical Science
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients with clinically diagnosed Topical Steroid Damaged Faces, willing to participate in the study will be included after taking proper informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnancy and lactation 2. Patient age less than 18years 3. Hypersensitivity to Tranexamic acid 4. Secondary infection of skin on affected area 5. Skin resurfacing by chemical peel, laser resurfacing and dermabrasion in the preceding 9months. 6. Any other treatment for TSDF in the preceding 4weeks. 7. Body dysmorphophobia 8. Uncooperative or unwilling to be a part of the study.

Design outcomes

Primary

MeasureTime frame
Clinician Erythema Assessment ScaleTimepoint: 4week, 8week, 12week

Secondary

MeasureTime frame
Occurrence of adverse events. Patient satisfaction will be evaluated by a Visual Analogic Scale.Timepoint: 4weeks, 8week, 12week

Countries

India

Contacts

Public ContactDr Pranami Kashyap

North Eastern Indira Gandhi Regional Institute of Health and Medical Science

pranami.kashyap14@gmail.com9089348156

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026